Clinical Trial
Semaglutide’s Remarkable Success in Kidney Disease Trial Prompts Early Completion
Anika Sharma
In a recent development surrounding the study of injectable semaglutide’s efficacy in chronic kidney disease, Novo Nordisk has found reason ...
Phesi partners with Krystelis to boost diversity in clinical trials
Anika Sharma
Clinical research and analytics specialist Phesi, in collaboration with Krystelis, has introduced a groundbreaking service aimed at enhancing the diversity ...
Abcuro’s KLRG1 Drug Gets $155M Boost for Clinical Trials
Anika Sharma
Abcuro Secures Impressive $155 Million in Oversubscribed Funding Round to Propel Clinical Trials of ABC008, a Groundbreaking Drug for Inclusion ...
J&J’s Rybrevant Wins in Rare Lung Cancer; Awaits Tagrisso Showdown
SG Tylor
Source – Johnson & Johnson In 2021, Johnson & Johnson’s Rybrevant received accelerated approval from the FDA, becoming the first ...
Advanced Classical Hodgkin Lymphoma: BrECADD Shows Noninferiority to eBEACOPP
SG Tylor
Source – BrECADD According to information from the Phase III HD21 trial (NCT02661503), which included patients with advanced classical Hodgkin ...
